These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39333051)

  • 1. Prevalence of Individuals With Multiple Diagnosed Genetic Diseases in the Undiagnosed Diseases Network.
    Gimeno AF; Tinker RJ; Furuta Y; ; Phillips JA
    Am J Med Genet A; 2024 Sep; ():e63888. PubMed ID: 39333051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science.
    Schoch K; Esteves C; Bican A; Spillmann R; Cope H; McConkie-Rosell A; Walley N; Fernandez L; Kohler JN; Bonner D; Reuter C; Stong N; Mulvihill JJ; Novacic D; Wolfe L; Abdelbaki A; Toro C; Tifft C; Malicdan M; Gahl W; Liu P; Newman J; Goldstein DB; Hom J; Sampson J; Wheeler MT; ; Cogan J; Bernstein JA; Adams DR; McCray AT; Shashi V
    Genet Med; 2021 Feb; 23(2):259-271. PubMed ID: 33093671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine Learning of Patient Characteristics to Predict Admission Outcomes in the Undiagnosed Diseases Network.
    Amiri H; Kohane IS;
    JAMA Netw Open; 2021 Feb; 4(2):e2036220. PubMed ID: 33630084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network.
    Spillmann RC; Tan QK; Reuter C; Schoch K; ; Kohler J; Bonner D; Zastrow D; Alkelai A; Baugh E; Cope H; Marwaha S; Wheeler MT; Bernstein JA; Shashi V;
    Genet Med; 2023 Apr; 25(4):100353. PubMed ID: 36481303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation in a national diagnostic research study: assessing the patient experience.
    Rosenfeld LE; LeBlanc K; Nagy A; Ego BK; ; McCray AT
    Orphanet J Rare Dis; 2023 Apr; 18(1):73. PubMed ID: 37032333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease.
    Splinter K; Adams DR; Bacino CA; Bellen HJ; Bernstein JA; Cheatle-Jarvela AM; Eng CM; Esteves C; Gahl WA; Hamid R; Jacob HJ; Kikani B; Koeller DM; Kohane IS; Lee BH; Loscalzo J; Luo X; McCray AT; Metz TO; Mulvihill JJ; Nelson SF; Palmer CGS; Phillips JA; Pick L; Postlethwait JH; Reuter C; Shashi V; Sweetser DA; Tifft CJ; Walley NM; Wangler MF; Westerfield M; Wheeler MT; Wise AL; Worthey EA; Yamamoto S; Ashley EA;
    N Engl J Med; 2018 Nov; 379(22):2131-2139. PubMed ID: 30304647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of undiagnosed diseases network applicants: implications for referring providers.
    Walley NM; Pena LDM; Hooper SR; Cope H; Jiang YH; McConkie-Rosell A; Sanders C; Schoch K; Spillmann RC; Strong K; McCray AT; Mazur P; Esteves C; LeBlanc K; ; Wise AL; Shashi V
    BMC Health Serv Res; 2018 Aug; 18(1):652. PubMed ID: 30134969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations of exome sequencing in detecting rare and undiagnosed diseases.
    Burdick KJ; Cogan JD; Rives LC; Robertson AK; Koziura ME; Brokamp E; Duncan L; Hannig V; Pfotenhauer J; Vanzo R; Paul MS; Bican A; Morgan T; Duis J; Newman JH; Hamid R; Phillips JA;
    Am J Med Genet A; 2020 Jun; 182(6):1400-1406. PubMed ID: 32190976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Missed diagnoses: Clinically relevant lessons learned through medical mysteries solved by the Undiagnosed Diseases Network.
    Cope H; Spillmann R; Rosenfeld JA; Brokamp E; Signer R; Schoch K; Glanton E; Sullivan JA; Macnamara E; Lincoln S; Golden-Grant K; ; Orengo JP; Clark G; Burrage LC; Posey JE; Punetha J; Robertson A; Cogan J; Phillips JA; Martinez-Agosto J; Shashi V
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1397. PubMed ID: 32730690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of transcriptome sequencing for rare Mendelian diseases.
    Lee H; Huang AY; Wang LK; Yoon AJ; Renteria G; Eskin A; Signer RH; Dorrani N; Nieves-Rodriguez S; Wan J; Douine ED; Woods JD; Dell'Angelica EC; Fogel BL; Martin MG; Butte MJ; Parker NH; Wang RT; Shieh PB; Wong DA; Gallant N; Singh KE; Tavyev Asher YJ; Sinsheimer JS; Krakow D; Loo SK; Allard P; Papp JC; ; Palmer CGS; Martinez-Agosto JA; Nelson SF
    Genet Med; 2020 Mar; 22(3):490-499. PubMed ID: 31607746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testing.
    Reuter CM; Kohler JN; Bonner D; Zastrow D; Fernandez L; Dries A; Marwaha S; Davidson J; Brokamp E; Herzog M; Hong J; Macnamara E; Rosenfeld JA; Schoch K; Spillmann R; ; Loscalzo J; Krier J; Stoler J; Sweetser D; Palmer CGS; Phillips JA; Shashi V; Adams DA; Yang Y; Ashley EA; Fisher PG; Mulvihill JJ; Bernstein JA; Wheeler MT
    J Genet Couns; 2019 Dec; 28(6):1107-1118. PubMed ID: 31478310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What Has the Undiagnosed Diseases Network Taught Us About the Clinical Applications of Genomic Testing?
    Murdock DR; Rosenfeld JA; Lee B
    Annu Rev Med; 2022 Jan; 73():575-585. PubMed ID: 35084988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for nonaccepted ones.
    Mulvihill JJ; Findley L; Ni W; Sinsheimer JS; Cole FS; Esteves C; Bernstein JA; Newman JH; Wheeler MT; Mokry JR;
    Genet Med; 2024 Oct; 26(10):101203. PubMed ID: 38967101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of mosaicism to genetic diseases and de novo pathogenic variants.
    Tinker RJ; Bastarache L; Ezell K; Kobren SN; Esteves C; Rosenfeld JA; Macnamara EF; Hamid R; Cogan JD; Rinker D; Mukharjee S; Glass I; Dipple K; Phillips JA;
    Am J Med Genet A; 2023 Oct; 191(10):2482-2492. PubMed ID: 37246601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and discovery: Insights from the NIH Undiagnosed Diseases Program.
    Montano C; Cassini T; Ziegler SG; Boehm M; Nicoli ER; Mindell JA; Soldatos AG; Manoli I; Wolfe L; Macnamara EF; Malicdan MCV; Adams DR; Tifft CJ; Toro C; Gahl WA
    J Inherit Metab Dis; 2022 Sep; 45(5):907-918. PubMed ID: 35490291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reported environmental exposures are inversely associated with obtaining a genetic diagnosis in the Undiagnosed Diseases Network.
    Silverman EK; Allard P; Loscalzo J; Mulvihill JJ; Korrick SA;
    Am J Med Genet A; 2019 Jun; 179(6):958-965. PubMed ID: 30903737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adults with lysosomal storage diseases in the undiagnosed diseases network.
    Xiao C; Koziura M; Cope H; Spillman R; Tan K; Hisama FM; Tifft CJ; Toro C
    Mol Genet Genomic Med; 2022 Sep; 10(9):e2013. PubMed ID: 35848209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying digenic disease genes via machine learning in the Undiagnosed Diseases Network.
    Mukherjee S; Cogan JD; Newman JH; Phillips JA; Hamid R; ; Meiler J; Capra JA
    Am J Hum Genet; 2021 Oct; 108(10):1946-1963. PubMed ID: 34529933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family genetic result communication in rare and undiagnosed disease communities: Understanding the practice.
    Studwell CM; Glanton E; ; Sinsheimer JS; Palmer CGS; LeBlanc K
    J Genet Couns; 2021 Apr; 30(2):439-447. PubMed ID: 33108040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing Equity in Rare Disease Research: Insights From the Undiagnosed Disease Network.
    Borja NA; Tinker RJ; Bivona SA; Smith CA; Locker TK; Fernandes S; ; Phillips JA; Stoler J; Taylor H; Zuchner S; Tekin M
    Am J Med Genet A; 2024 Oct; ():e63904. PubMed ID: 39400494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.